Table 3.
Spatiotemporal Gait Parameters of Participants
| PDSN+ | PDSN- | P | |
|---|---|---|---|
| SL | 0.93±0.23 | 0.99±0.24 | 0.098 |
| GV | 0.76±0.23 | 0.84±0.22 | 0.126 |
| CA | 97.47±20.83 | 101.28±19.45 | 0.415 |
| ST | 1.34±0.65 | 1.25±0.39 | 0.508 |
| StPT(%) | 64.71±5.51 | 63.39±6.62 | 0.322 |
| SwPT(%) | 34.90±5.19 | 36.63±6.64 | 0.180 |
| CV-SL | 28.21±6.92 | 25.63±7.02 | 0.042 |
| CV-ST | 22.51±5.21 | 24.31±9.46 | 0.992 |
| CV-StPT | 17.51±3.33 | 17.92±7.10 | 0.376 |
| CV-SwPT | 23.43±5.04 | 23.33±8.04 | 0.337 |
Note: Data was listed as mean ± SD; bold font represented significant results.
Abbreviations: PD, Parkinson’s disease; SN, substantia nigra; PDSN+, PD patients with SN hyperechogenicity; PDSN-, PD patients with normal SN echogenicity; SL, stride length; GV, gait velocity; CA, cadence; ST, stride time; StPT, stance phase time; SwPT, swing phase time; CV, coefficient of variation.